According to the Ordos announcement, the cumulative deviation value of the closing price increase of the company's A shares exceeded 20% for three consecutive trading days on January 5, 6, and 7, 2026, which is an abnormal fluctuation. After self-inspection and inquiries with controlling shareholders and actual controllers, the company's production and operation were normal; there were no major undisclosed information that should be disclosed; no media reports, market rumors or hot concepts affecting stock prices were discovered; and senior management Dong, controlling shareholders, and their co-actors did not trade the company's shares during the period of abnormal fluctuations. The company reminds investors to pay attention to transaction risks and invest rationally.

According to the Ordos announcement, the cumulative deviation value of the closing price increase of the company's A shares exceeded 20% for three consecutive trading days on January 5, 6, and 7, 2026, which is an abnormal fluctuation. After self-inspection and inquiries with controlling shareholders and actual controllers, the company's production and operation were normal; there were no major undisclosed information that should be disclosed; no media reports, market rumors or hot concepts affecting stock prices were discovered; and senior management Dong, controlling shareholders, and their co-actors did not trade the company's shares during the period of abnormal fluctuations. The company reminds investors to pay attention to transaction risks and invest rationally.